Ruxolitinib
API STANDARDS    
Availability: In-Stock
Dispatch by : 18-Nov-2019 5:00 PM
CAT No. CS-T-61211
Category API Standards
Parent API Ruxolitinib
CAS 941678-49-5
Mol. Weight 306.36 mol/g
Mol. Formula C17H18N6
Product Description
Stock Status In-Stock
Dispatch by : 18-Nov-2019 5:00 PM
Synonyms (R)--Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile; INCB 018424; (R)-Ruxolitinib.
Purity (%) >98%
Application Notes Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);
Smileys N#CC[C@H](C1CCCC1)N2C=C(C3=C(C=CN4)C4=NC=N3)C=N2
View COA View MSDS
The balance used are calibrated with weights Traceable to National Standards NIST for accuracy

Quality Assurance

c1
ISO 9001:2005
c4
OHSAS 18001:2007
c5
ISO 14001:2005
c5
NIST Calibrated
Related Results

- API Standards of Ruxolitinib
- Stable Isotopes of Ruxolitinib
- Metabolites of Ruxolitinib
- Impurities of Ruxolitinib
- Glucuronides of Ruxolitinib
- Intermediates of Ruxolitinib

You may be also interested
Have questions about this product or Require Pricing?
Let us help you.
Our automated system will send you a quote for your specific qty along with Discount, timelines or Stock status.

Stock Status   Bulk Quote   Required Pricing

Guaranteed Delivery
We ship worldwide through leading logistics partners.
Our shipment reaches you from our stock point closest to your country (US)
Return Policy

Returns accepted if compound not as described

Buyer Protection

Full Refund if you don't receive your order within stipulated timeline
Full Refund, if the product is not as described